Eline S. van Hattum

Eline S. van Hattum

Auto-generated profile, based on publicly available information

Eline S. van Hattum

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
RKRobert J.C.M.F. de Kleijn
Robert J.C.M.F. de Kleijn
LSLudo Schropp
Ludo Schropp
EHEline S. van Hattum
Eline S. van Hattum
Çağdaş ÜnlüÇağdaş Ünlü
Çağdaş Ünlü
SMSaskia Middeldorp
Saskia Middeldorp
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
Primary deep vein thrombosis of the upper extremity (UEDVT) is a rare condition but up to 60% of patients may develop post‐thrombotic syndrome in the upper extremity (UE‐PTS) with significant morbidity and decreased quality of life. However, there is no universally accepted method to diagnose and classify UE‐PTS, hampering scientific research on UEDVT treatment. Through this international Delphi consensus study we aimed to determine what a clinical score for diagnosing UE‐PTS should entail. An online focus group survey among 20 patients treated for UEDVT was performed to provide clinical parameters before the start of a four round electronic Delphi consensus study among 25 international experts. The CREDES recommendations on Conducting and Reporting Delphi Studies were applied. Open text questions, multiple selection questions, and 9‐point Likert scales were used. Consensus was set at 70% agreement. After four rounds, agreement was reached on a composite score of five symptoms and three clinical signs, combined with a functional disability score. The signs and symptom will each be scored on a severity scale of 0–3 and the total score expressed as an ordinal variable; no/mild/moderate/or severe PTS. The functional disability portion measures the impact of the signs and symptoms on the functionality of the patient’s arm. Consensus was reached on a composite score of signs and symptoms of UE‐PTS combined with a functional disability score. Clinical validation of the UE‐PTS score in a large patient cohort is mandatory to facilitate application in future research.

15 July 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
LSLudo Schropp
Ludo Schropp
EVEvert-jan Vonken
Evert-jan Vonken
MSMaarten L.J. Smits
Maarten L.J. Smits
EGEva K.L. de Graaf
Eva K.L. de Graaf
SGSanne E. Gillebaard
Sanne E. Gillebaard
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
Diagnostic criteria for venous and arterial thoracic outlet syndrome (TOS) are heterogeneous. Detailed guidance on imaging methods and reporting is lacking. This study examined the reliability of a standardised method to quantify vascular compression in the thoracic outlet on dynamic computed tomography (CT) and magnetic resonance (MR) imaging. A standardised and pragmatic method to calculate changes in area using the major and minor diameter of the subclavian artery and vein in the sagittal plane during adduction and abduction was investigated. In a single TOS expertise centre, all CT and MR scans performed according to the TOS protocol were retrospectively identified and independently analysed by four observers using the pre-defined measurement method. Intraclass correlation coefficients were calculated to assess inter- and intra-observer reliability, with thresholds of < 0.5 (poor), 0.5 - 0.75 (moderate), > 0.75 - 0.9 (good), and > 0.9 (excellent). Fifty one CT scans (102 arms) and 58 MR scans (116 arms) were analysed. Venous compression (> 50%) was more prevalent compared with arterial compression both in the CT (51% vs. 16%) and MR (64% vs. 2%) cohorts. Inter-observer agreement for CT measurements was 0.79 (95% confidence interval [CI] 0.69 - 0.86) and 0.82 (95% CI 0.75 - 0.88) for arterial and venous compression, respectively; intra-observer agreement was 0.80 (95% CI 0.72 - 0.86) and 0.84 (95% CI 0.76 - 0.89). For MR measurements, inter-observer agreement was 0.36 (95% CI 0.16 - 0.53) and 0.38 (95% CI 0.20 - 0.54) for arterial and venous compression, respectively; intra-observer agreement was 0.39 (95% CI 0.23 - 0.54) and 0.60 (95% CI 0.47 - 0.71). The pre-defined measurement protocol applied on standard CT imaging proved reliable for both arterial and venous quantification of vascular compression. The same measurement protocol applied on MR imaging showed poor inter- and intra-observer reliability. Use of this standardised measurement protocol with CT in prospective multicentre studies on vascular TOS is advocated.

17 October 2025 in EJVES Vascular Forum
Verified
Journal Article
Open access
OAOumaima Aouam
Oumaima Aouam
CBCarolijn de Bresser
Carolijn de Bresser
EHEline S. van Hattum
Eline S. van Hattum
WFW. Marnix de Fijter
W. Marnix de Fijter
HJHidde Jongsma
Hidde Jongsma
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
Free floating thrombus in the carotid artery (cFFT) is a rare and poorly understood condition with an unclear definition and diagnostic criteria. This systematic review aimed to propose a reporting standard to ensure diagnostic consistency and a universal definition of cFFT. PubMed and EMBASE were systematically searched from inception until 01 May 2025, using terms including “free floating thrombus” and “carotid”, along with imaging modalities. Eligibility criteria included studies on patients with cFFT, diagnosed through well defined imaging criteria. Two authors independently screened eligible literature and extracted data. Study quality was assessed with the Methodological Index for Non-Randomized Studies (MINORS) score. The composite endpoint was the radiological description of cFFT per imaging modality. A systematic search identified 611 publications, from which 20 were included. These studies were predominantly of low quality, with a mean MINORS score of 9 for non-comparative and 16 for comparative studies. These 20 studies identified 17 distinct imaging based descriptions of cFFT. The descriptions were derived from five different imaging modalities, encompassing both static and dynamic imaging. Computed tomography angiography (CTA) was the most reported modality, followed by duplex ultrasound (DUS). On CTA, cFFT is diagnosed as a thrombus with circumferential flow, proximal attachment to the vessel wall, and extending distally in the lumen. On DUS, cFFT is diagnosed by circumferential flow, attachment to the arterial wall, and synchronous movement with the cardiac cycle. The published literature lacks high quality studies. It is suggested that the diagnosis of cFFT requires static imaging, preferably with CTA. If static imaging is inconclusive, a dedicated dynamic assessment by DUS, performed by an experienced sonographer, is suggested. The proposed definition aims to standardise the diagnostic workflow for cFFT, thereby ensuring consistent interpretation and unified terminology across research and clinical practice, which should also enhance individual patient data meta-analyses on cFFT in the future.

4 March 2026 in Journal of Vascular Surgery
Verified
Journal Article
Open access
OAOumaima Aouam
Oumaima Aouam
CBCarolijn de Bresser
Carolijn de Bresser
EHEline S. van Hattum
Eline S. van Hattum
WFW. Marnix de Fijter
W. Marnix de Fijter
HJHidde Jongsma
Hidde Jongsma
Gert Jan de BorstGert Jan de Borst
Gert Jan de Borst
A free-floating thrombus in the carotid artery (cFFT) is a high-risk vascular condition for stroke. Treatment recommendations are lacking. This systematic review aimed to identify the safety and effectiveness of existing management strategies for cFFT. PubMed and Embase were systematically searched from inception to May 2025, using search terms including "free-floating thrombus" and "carotid," and treatment strategies. Eligible studies reported on treatment and clinical outcomes. Two authors independently screened eligible literature and extracted data. Study quality was assessed with the Methodological Index for Non-Randomized Studies score (MINORS score). Primary end points were the composite of any nonfatal stroke and all-cause death (death/stroke) at the short-term (30 days) follow-up after initial treatment. Our literature search revealed 11 studies, encompassing 179 patients with cFFT. These studies were predominantly of low quality, with a mean MINORS score of 9 for noncomparative studies and 15 for comparative studies; notably, no randomized controlled studies were identified. Twenty treatment strategies were identified, grouped as antithrombotic medication (AM; n = 120/179 [67.0%]), or AM combined with endovascular treatment (EVT) (n = 20/179 [11.2%]), carotid endarterectomy (CEA) (n = 38/179 [21.2%]), and combined EVT + CEA (n = 1/179 [0.6%]). Sequential treatments were analyzed by timing: those initiated before 30 days contributed to short-term outcomes and those thereafter to long-term outcomes. Short-term combined death/stroke rates were reportedly highest with AM alone (n = 8/120 [6.7%]), followed by EVT (n = 1/20 [5.0%]) and CEA (n = 1/38 [2.6%]). The AM group reported a short-term all-cause death rate of 5.0% (n = 6/120) and nonfatal stroke rate of 1.7% (n = 2/120). Long-term outcomes occurred solely in the AM group, yielding a death/stroke rate of 6.5% (n = 3/46), comprising two deaths (n = 2/46, 4.3%) and one stroke (n = 1/46, 2.2%). The published literature on cFFT is limited and lacks high-quality studies. This review suggests that all currently reported treatment strategies are associated with a considerable risk for stroke or death. Anticoagulation alone appears to be inadequate, thereby challenging current European Society for Vascular Surgery guideline recommendations, whereas the results for CEA suggest it may represent a more favorable option in patients amenable to surgery. These findings should be interpreted with caution given the small number of patients included. Nevertheless, our data may help to inform the design of future studies and contribute to the development of more standardized treatment strategies.

5 October 2021 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
HGH. Stephan Goedee
H. Stephan Goedee
ASAntje A. Seeber
Antje A. Seeber
EHEline S. van Hattum
Eline S. van Hattum

6 May 2026 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Open access
THTjep Hoedemakers
Tjep Hoedemakers
LMLara.T. Mascini
Lara.T. Mascini
BPBart-Jeroen Petri
Bart-Jeroen Petri
GBGert J. de Borst
Gert J. de Borst
EHEline S. van Hattum
Eline S. van Hattum